Top 10 Clean Energy Stocks To Watch Right Now

Things are moving fast in renewable energy. Really fast. Consider that in 2008 wind farms supplied just 1.5% of all electricity in the United States. But by 2019 wind power is expected to contribute 6.9% of American electricity and overtake hydropower as the top renewable energy source.

The rise of wind power wouldn’t have been possible without two companies in particular, which combine to own 20.7 gigawatts of wind capacity, or about 24% of the country’s total. Investors wouldn’t be surprised to learn that clean energy provider NextEra Energy is one of the renewable energy stocks most important to American wind power. However, the relatively unheard of natural gas and electric utility Xcel Energy (NASDAQ:XEL) doesn’t seem to garner nearly the same level of attention. Overlooking it could be a mistake.

With 10-year total returns of 226% and plans to grow its dividend and EPS at annual clips of 5% to 7% — all while investing billions in new wind and solar capacity — it could be the best renewable energy stock you’ve never heard of.

Top 10 Clean Energy Stocks To Watch Right Now: AVEO Pharmaceuticals, Inc.(AVEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on AVEO Pharmaceuticals (AVEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By George Budwell]

    Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) gained a healthy 10.7% last month, according to data from S&P Global Market Intelligence. The spark?

  • [By Shane Hupp]

    AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)’s share price traded down 24.2% during mid-day trading on Tuesday . The company traded as low as $2.15 and last traded at $2.16. 9,547,354 shares traded hands during trading, an increase of 395% from the average session volume of 1,930,275 shares. The stock had previously closed at $2.85.

  • [By Joseph Griffin]

    These are some of the media headlines that may have impacted Accern’s scoring:

    Get AVEO Pharmaceuticals alerts:

    Deadline Upcoming in $15 Million Settlement in the AVEO Pharmaceuticals Inc (NASDAQ:AVEO) Investor Lawsuit (digitaljournal.com) $1.35 Million in Sales Expected for AVEO Pharmaceuticals, Inc. (AVEO) This Quarter (americanbankingnews.com) AVEO Pharmaceuticals, Inc. (AVEO) Expected to Announce Earnings of -$0.06 Per Share (americanbankingnews.com) Equity Opportunities Iv Growth Purchases 236,479 Shares of AVEO Pharmaceuticals, Inc. (AVEO) Stock (americanbankingnews.com) AVEO Pharmaceuticals, Inc. (AVEO) Major Shareholder Buys $392,301.27 in Stock (americanbankingnews.com)

    Several analysts recently weighed in on the company. Zacks Investment Research raised AVEO Pharmaceuticals from a “strong sell” rating to a “hold” rating in a research note on Friday, May 4th. BidaskClub raised AVEO Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research note on Saturday, March 24th. Finally, ValuEngine raised AVEO Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $4.05.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on AVEO Pharmaceuticals (AVEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Watch Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Todd Campbell]

    After clinical-stage competitor Loxo Oncology (NASDAQ:LOXO) presented impressive data at the American Society of Clinical Oncology (ASCO) meeting this weekend, shares in Blueprint Medicines (NASDAQ:BPMC) tumbled by as much as 16% on Monday.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Blueprint Medicines (BPMC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    ValuEngine downgraded shares of Blueprint Medicines (NASDAQ:BPMC) from a strong-buy rating to a buy rating in a report issued on Monday morning.

    BPMC has been the topic of a number of other reports. JMP Securities lowered their price target on Blueprint Medicines from $109.00 to $103.00 and set a buy rating on the stock in a research report on Monday, June 4th. Zacks Investment Research upgraded Blueprint Medicines from a sell rating to a hold rating in a research report on Tuesday, July 3rd. BidaskClub upgraded Blueprint Medicines from a sell rating to a hold rating in a research report on Friday, August 3rd. Finally, Cowen reiterated a buy rating on shares of Blueprint Medicines in a research report on Wednesday, August 1st. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and an average target price of $91.80.

Top 10 Clean Energy Stocks To Watch Right Now: Natural Health Trends Corp.(NHTC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Shane Hupp]

    Natural Health Trends (NASDAQ:NHTC) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued on Friday.

  • [By Max Byerly]

    Central Garden & Pet (NASDAQ: CENT) and Natural Health Trends (NASDAQ:NHTC) are both consumer discretionary companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation.

Top 10 Clean Energy Stocks To Watch Right Now: Xcerra Corporation(XCRA)

Advisors’ Opinion:

  • [By Max Byerly]

    LTX-Credence Co. common stock (NASDAQ:XCRA) – Analysts at B. Riley increased their FY2018 earnings per share estimates for LTX-Credence Co. common stock in a research note issued on Tuesday, May 29th. B. Riley analyst C. Ellis now forecasts that the semiconductor company will post earnings of $1.03 per share for the year, up from their prior estimate of $0.99. B. Riley has a “Neutral” rating and a $14.00 price objective on the stock. B. Riley also issued estimates for LTX-Credence Co. common stock’s Q4 2018 earnings at $0.27 EPS, Q1 2019 earnings at $0.27 EPS, Q2 2019 earnings at $0.23 EPS, Q3 2019 earnings at $0.28 EPS, Q4 2019 earnings at $0.32 EPS, FY2019 earnings at $1.09 EPS and FY2020 earnings at $1.30 EPS.

  • [By Rich Smith]

    “Robust industry trends” in the semiconductor industry, argues Davidson, give this “leading provider of semiconductor test handlers and … emerging player in the associated contactor and vision inspection markets” an “ample runway for growth.” Cohu’s also in the process of acquiring one of its top competitors, Xcerra Corporation (NASDAQ:XCRA), in a deal slated to close next quarter, which will add scale to Cohu’s business even as it removes a source of price competition.

  • [By Ethan Ryder]

    These are some of the news headlines that may have effected Accern Sentiment’s scoring:

    Get LTX-Credence Co. common stock alerts:

    LTX-Credence Co. common stock (XCRA) Receives Consensus Recommendation of “Hold” from Brokerages (americanbankingnews.com) Why Xcerra (XCRA) Could Beat Earnings Estimates Again (finance.yahoo.com) Cohu, Inc. — Moody’s rates Cohu’s CFR at B1; new Senior Secured Term Loan B at B1; outlook stable (finance.yahoo.com) Brokerages Expect LTX-Credence Co. common stock (XCRA) Will Announce Earnings of $0.28 Per Share (americanbankingnews.com)

    XCRA traded down $0.13 during midday trading on Friday, reaching $14.00. The company’s stock had a trading volume of 315,922 shares, compared to its average volume of 270,685. The firm has a market capitalization of $768.81 million, a P/E ratio of 28.57, a price-to-earnings-growth ratio of 1.06 and a beta of 1.46. The company has a quick ratio of 3.35, a current ratio of 4.40 and a debt-to-equity ratio of 0.01. LTX-Credence Co. common stock has a twelve month low of $9.50 and a twelve month high of $14.87.

  • [By Garrett Baldwin]

    Get an exclusive invitation to meet Tim before everyone else right here.

    Three Stocks to Watch Today: LC, GE, GS
    General Electric Co. (NYSE: GE) has ousted its CEO John Flannery. Shares are up more than 10% as investors celebrated the news. GE has been mired in a slump, particularly its turbine business. The firm’s new CEO is H. Lawrence Culp, Jr., the former CEO of the industrial firm Danaher. Shares of LendingClub Corp. (NYSE: LC) are under pressure after the SEC charged one of the firm’s divisions with mishandling client money. This weekend, the firm reached a settlement with regulators on charges that the firm inflated its revenue and made changes to products to make the firm look healthier than it is. As a result, the firm’s board of directors forced CEO Renaud Laplanche to resign. Goldman Sachs Group Inc. (NYSE: GS) has replaced CEO Lloyd Blankfein, who has stepped down after more than a decade at the helm at one of Wall Street’s most iconic banks. David Solomon – who has previously served as the firm’s president and COO – will now bet the new CEO. His tenure begins at a tough time for Goldman as the bank struggles with lower trading desk revenues. Look for earnings reports today from Cal-Maine Foods Inc. (NASDAQ: CALM) and Xcerra Corp. (NASDAQ: XCRA).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top 10 Clean Energy Stocks To Watch Right Now: Equity Commonwealth(EQC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Neuberger Berman Group LLC lowered its stake in HRPT Properties Trust (NYSE:EQC) by 62.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,127 shares of the real estate investment trust’s stock after selling 15,165 shares during the period. Neuberger Berman Group LLC’s holdings in HRPT Properties Trust were worth $307,000 at the end of the most recent quarter.

  • [By ]

    1. Equity Commonwealth (NYSE: EQC)
    It may be surprising to find a real estate investment trust (REIT) on this list, but Sam Zell’s investment vehicle is preparing itself for a possible debt bomb. Zell’s ability to foresee economic trends has built him great wealth. Now, he is selling EQC’s holdings to create a cash hoard ready to deploy when debt causes real estate prices to plunge again.  

  • [By Matthew DiLallo]

    Equity Commonwealth (NYSE:EQC) continued to steadily sell off its portfolio of real estate holdings, closing three more sales during the quarter, bringing its property count down to 13. As a result, cash flow kept declining. That trend doesn’t show any signs of ending given that the company has more properties on the market and doesn’t yet see a good opportunity to make acquisitions. 

  • [By Stephan Byrd]

    HRPT Properties Trust (NYSE:EQC) had its price target boosted by investment analysts at JMP Securities to $33.00 in a report issued on Tuesday. The brokerage currently has a “market outperform” rating on the real estate investment trust’s stock. JMP Securities’ target price points to a potential upside of 4.04% from the company’s previous close.

Top 10 Clean Energy Stocks To Watch Right Now: Infinity Pharmaceuticals, Inc.(INFI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Infinity Pharmaceuticals Inc. (NASDAQ:INFI) CEO Adelene Q. Perkins sold 5,000 shares of Infinity Pharmaceuticals stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $2.82, for a total transaction of $14,100.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

  • [By Logan Wallace]

    ValuEngine upgraded shares of Infinity Pharmaceuticals (NASDAQ:INFI) from a sell rating to a hold rating in a report published on Saturday morning.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Infinity Pharmaceuticals (INFI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Watch Right Now: Argo Pantes Tbk PT (ARGO)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the news stories that may have impacted Accern’s rankings:

    Get Argo Group alerts:

    Cosgrave Property Group is close to selling its Liberty Shopping Centre in London (thetimes.co.uk) Form 4 Argo Group International For: Sep 05 Filed by: Bullock Jay Stanley (streetinsider.com) Insider Selling: Argo Group (ARGO) CFO Sells 12,323 Shares of Stock (americanbankingnews.com) Argo Blockchain touts promise of cryptos despite falling prices (stockmarketwire.com) Argo Blockchain shrugs off crypto slide and looks long term (proactiveinvestors.co.uk)

    Shares of ARGO traded down $0.30 during midday trading on Friday, hitting $62.95. The stock had a trading volume of 47,644 shares, compared to its average volume of 126,574. Argo Group has a fifty-two week low of $49.69 and a fifty-two week high of $65.90.

  • [By Logan Wallace]

    These are some of the media headlines that may have impacted Accern Sentiment’s scoring:

    Get Argo Group alerts:

    Labour Day game against Tiger-Cats pivotal for Argonauts’ playoff chances (torontosun.com) Argo Group (ARGO) Director John R. Power, Jr. Sells 5,355 Shares (americanbankingnews.com) Keeping supermarket risks in check is a slippery business (insurancebusinessmag.com) Video: ‘Sea Change’ Highlights Female Sailors (bernews.com) Argo names new US specialty programmes leader (intelligentinsurer.com)

    ARGO has been the topic of several research analyst reports. Zacks Investment Research cut shares of Argo Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 10th. Raymond James upped their price target on shares of Argo Group from $65.00 to $68.00 and gave the stock a “strong-buy” rating in a report on Tuesday, May 8th. Finally, Keefe, Bruyette & Woods upped their price target on shares of Argo Group to $69.00 and gave the stock an “outperform” rating in a report on Tuesday, August 7th.

Top 10 Clean Energy Stocks To Watch Right Now: CHS Inc(CHSCL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CHS (NASDAQ:CHSCL) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Friday.

Top 10 Clean Energy Stocks To Watch Right Now: Jewett-Cameron Trading Company(JCTCF)

Advisors’ Opinion:

  • [By Max Byerly]

    Media headlines about Jewett-Cameron Trading (NASDAQ:JCTCF) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Jewett-Cameron Trading earned a news impact score of 0.08 on Accern’s scale. Accern also gave news coverage about the company an impact score of 45.2200105194978 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Ethan Ryder]

    Jewett-Cameron Trading Company Ltd (NASDAQ:JCTCF) Director Donald M. Boone sold 3,097 shares of the firm’s stock in a transaction that occurred on Wednesday, September 5th. The shares were sold at an average price of $8.59, for a total value of $26,603.23. Following the completion of the sale, the director now directly owns 1,326,242 shares of the company’s stock, valued at $11,392,418.78. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

  • [By Ethan Ryder]

    Jewett-Cameron Trading Co (NASDAQ:JCTCF) Director Donald M. Boone sold 4,401 shares of the company’s stock in a transaction dated Friday, June 1st. The shares were sold at an average price of $7.89, for a total transaction of $34,723.89. Following the sale, the director now directly owns 1,369,743 shares of the company’s stock, valued at $10,807,272.27. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Top 10 Clean Energy Stocks To Watch Right Now: BP Prudhoe Bay Royalty Trust(BPT)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market had a tumultuous session on Wednesday, as major benchmarks started the day weak but bounced back in the afternoon. Investors weren’t happy with the current state of geopolitical uncertainty, with trade disputes threatening to become larger problems than ever. But the release of the minutes of the latest meeting of the Federal Reserve’s monetary policy committee convinced many that the central bank will be slow to do lasting damage to the economic expansion, remaining measured in the pace of its interest rate increases. Moreover, some companies had good news that sent their shares higher. Tiffany (NYSE:TIF), BP Prudhoe Bay Royalty Trust (NYSE:BPT), and Ralph Lauren (NYSE:RL) were among the best performers on the day. Here’s why they did so well.

  • [By Max Byerly]

    Blockport (CURRENCY:BPT) traded down 4.1% against the dollar during the 1 day period ending at 23:00 PM ET on August 12th. In the last week, Blockport has traded down 26.3% against the dollar. One Blockport token can now be bought for $0.0894 or 0.00001414 BTC on exchanges including Kucoin and IDEX. Blockport has a market capitalization of $4.73 million and approximately $7,133.00 worth of Blockport was traded on exchanges in the last 24 hours.

  • [By Ethan Ryder]

    Blockport (CURRENCY:BPT) traded down 0.3% against the U.S. dollar during the 1-day period ending at 23:00 PM ET on September 14th. One Blockport token can now be bought for $0.0819 or 0.00001261 BTC on popular cryptocurrency exchanges including Kucoin and IDEX. Over the last week, Blockport has traded down 2.3% against the U.S. dollar. Blockport has a total market cap of $4.33 million and $60,265.00 worth of Blockport was traded on exchanges in the last 24 hours.

Leave a Reply

Your email address will not be published. Required fields are marked *